UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
 
May 22, 2024
 
Commission File Number 001-14978
 
SMITH & NEPHEW plc
(Registrant’s name)
 
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
 (Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F a         Form 40-F __
 
 
 

 
 
SMITH & NEPHEW PLC
 
22 May 2024
 
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
 
1.   VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
 
On 20 and 21 May 2024, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.
 
All figures in these columns are stated to 6 decimal places where applicable.
 
i.    FINAL VESTING OF 2021 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
 
The awards were granted under the Global Share Plan 2020 on 21 May 2021. One third of the Shares vested on 21 May 2022, a further third vested on 21 May 2023 and the final third vested on 21 May 2024. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Smith & Nephew plc
LEI
213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification code
ISIN: GB0009223206
Nature of the transaction
Final vesting on 21 May 2024 of Conditional Share awards granted on 21 May 2021 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability
Date of Transaction
2024 - 05 - 21
Place of Transaction
London Stock Exchange (XLON)
 
 
Name
(Position)
 
 
Status
 
Price (£)
 
Volume
 
Aggregated information
 
Craig Gaffin
President, Global Orthopaedics
 
PDMR
10.1175
 
1,522 (of which 372 were sold and 1,150 were retained.)
 
N/A Single Transaction
 
Scott Schaffner
(President Sports Medicine)
 
PDMR
10.1175
 
1,141 (of which 279 were sold and 862 retained.)
 
N/A Single Transaction
 
 
 
ii.   PARTIAL VESTING OF 2022 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
 
The awards were granted under the Global Share Plan 2020 on 12 August 2022. One quarter of the Shares vested on 20 May 2023, a further quarter vested on 20 May 2024 and the final half will vest on 20 May 2025. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Smith & Nephew plc
LEI
213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification code
ISIN: GB0009223206
Nature of the transaction
Partial vesting on 20 May 2024 of Conditional Share awards granted on 12 August 2022 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability
Date of Transaction
2024 - 05 - 20
Place of Transaction
London Stock Exchange (XLON)
 
 
Name
(Position)
 
 
Status
 
Price (£)
 
Volume
 
Aggregated information
 
Elga Lohler
(Chief HR Officer)
 
PDMR
10.290135
10,088 (of which 4,010 were sold and 6,078 were retained.)
 
N/A Single Transaction
 
 
 
iii.  PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
 
The awards were granted under the Global Share Plan 2020 on 19 May 2023. One quarter of the Shares vested on 20 May 2024, a further quarter will vest on 19 May 2025 and the final half will vest on 19 May 2026. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Smith & Nephew plc
LEI
213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification code
ISIN: GB0009223206
Nature of the transaction
Partial vesting on 20 May 2024 of Conditional Share awards granted on 19 May 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability
Date of Transaction
2024 - 05 - 20
Place of Transaction
London Stock Exchange (XLON)
 
 
Name
(Position)
 
 
Status
 
Price (£)
 
Volume
 
Aggregated information
 
Craig Gaffin
President, Global Orthopaedics
 
PDMR
10.290135
1,551 (of which 379 were sold and 1,172 were retained.)
 
N/A Single Transaction
 
 
 
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
 
Tel:  +44 (0)1923 477100
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
 
Smith & Nephew plc
 
 
(Registrant)
 
 
 
 
 
 
Date: May 22, 2024
By:
/s/ Helen Barraclough
 
 
Helen Barraclough
 
 
Company Secretary